Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Block Listing Return

8 Oct 2021 07:00

RNS Number : 4315O
Silence Therapeutics PLC
08 October 2021
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 8th October 2021

 

Name of applicant:

Silence Therapeutics plc

Name of scheme:

Silence Therapeutics plc 2018 Employee Long Term Incentive Plan

Number and class of securities originally admitted

3,300,000 of 5 pence each

Date of admission

31st March 2021

Period of return:

From:

31st March 2021

To:

30th September 2021

Balance of unallotted securities under scheme(s) from previous return:

3,300,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

378,159

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2,921,841

 

Name of contact:

James Douglas

Telephone number of contact:

0799 003 0716

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRMRBBTMTTMTPB
Date   Source Headline
6th Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics Plc
5th Oct 20102:08 pmRNSForm 8.3 - Silence Therapeutics PLC
4th Oct 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
1st Oct 20103:19 pmRNSForm 8.3 - Silence Therapeutics plc
1st Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics
30th Sep 20101:48 pmRNSForm 8.3 - [Silence Therapeutics]
29th Sep 20107:00 amPRNForm 8.3 - Silence Therapeutics plc
23rd Sep 20102:45 pmPRNForm 8.3 - Silence Therapeutics Plc
22nd Sep 20102:42 pmPRNForm 8.3 - Silence Therapeutics plc
21st Sep 20101:38 pmRNSForm 8.3 - Silence Therapeutics
20th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20102:54 pmPRNForm 8.3 - Silence Therapeutics plc
15th Sep 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
14th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics
14th Sep 201011:22 amRNSForm 8.3 - Silence Therapeutics plc
14th Sep 20109:45 amRNSForm 8.5 (EPT/NON-RI)
14th Sep 20107:00 amRNSChange of Adviser
13th Sep 20101:45 pmRNSForm 8.5 (EPT/NON-RI)
10th Sep 20103:24 pmRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
10th Sep 20102:06 pmRNSForm 8 (OPD) - Silence Therapeutics plc
10th Sep 201011:19 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 201011:48 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20104:23 pmRNSForm 8.5 - Silence Therapeutics PLC
8th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics PLC
8th Sep 20102:43 pmRNSForm 8.3 - SILENCE THERAPEUTICS PLC
8th Sep 20101:35 pmRNSForm 8.3 - [Silence Therapeutics Plc Amendment]
8th Sep 20101:02 pmRNSForm 8.3 - Silence Therapeutics plc
8th Sep 20101:00 pmRNSForm 8.3 - Silence Therapeutics Plc
8th Sep 201012:42 pmRNSForm 8.3 - [Silence Therapeutics Plc)
8th Sep 201011:09 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20107:00 amRNSNon Regulatory - Patent Issuance
7th Sep 20103:13 pmRNSForm 8.3 - Silence Therapeutics Plc
7th Sep 20102:41 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 20102:39 pmPRNForm 8.3 - Silence Therapeutics Plc
7th Sep 201012:46 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 201012:19 pmRNSForm 8.5 - Silence Therapeutics Plc (amendment)
7th Sep 201011:53 amRNSForm 8.5 - Silence Therapeutics
7th Sep 201010:58 amRNSForm 8.5 (EPT/NON-RI)
6th Sep 20104:40 pmRNSSecond Price Monitoring Extn
6th Sep 20104:35 pmRNSPrice Monitoring Extension
6th Sep 20103:14 pmRNSPotential Offer
19th Aug 20104:35 pmRNSExclusive option agreement with Novartis
18th Aug 20107:00 amRNSChange of Auditor and Notice of Interim Results
11th Aug 20107:00 amRNSZamore Patent Issuance
14th Jul 20102:32 pmRNSHolding(s) in Company
14th Jul 20107:00 amRNSCollaboraton extension with AstraZeneca
9th Jul 20104:35 pmRNSPrice Monitoring Extension
18th Jun 201012:51 pmPRNAll Resolutions Passed at Silence's (AIM: SLN) AGM
11th May 20107:00 amPRNSilence (AIM:SLN) to Present at Investor Conferences
29th Apr 20107:00 amPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.